Ranwei Li

576 total citations
30 papers, 411 citations indexed

About

Ranwei Li is a scholar working on Molecular Biology, Cancer Research and Artificial Intelligence. According to data from OpenAlex, Ranwei Li has authored 30 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Artificial Intelligence. Recurrent topics in Ranwei Li's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (5 papers) and Target Tracking and Data Fusion in Sensor Networks (5 papers). Ranwei Li is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (5 papers) and Target Tracking and Data Fusion in Sensor Networks (5 papers). Ranwei Li collaborates with scholars based in China and Austria. Ranwei Li's co-authors include Xin Di, Min Zhao, Xin Jin, Ke Wang, Shan Cong, Chang Fu Tian, Ke Wang, Tiecheng Liu, Lijing Zhao and Jiaying Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ranwei Li

28 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranwei Li China 12 258 144 45 38 30 30 411
He Zha China 13 330 1.3× 184 1.3× 33 0.7× 38 1.0× 51 1.7× 21 471
Pavithra Shyamsunder Singapore 13 286 1.1× 68 0.5× 33 0.7× 42 1.1× 51 1.7× 32 474
Yuling An China 8 238 0.9× 112 0.8× 92 2.0× 85 2.2× 13 0.4× 24 421
Zachary VanGundy United States 10 215 0.8× 41 0.3× 28 0.6× 58 1.5× 26 0.9× 16 399
Yubo Zhao China 11 196 0.8× 111 0.8× 46 1.0× 32 0.8× 37 1.2× 29 407
Xiang Yao Su China 11 162 0.6× 52 0.4× 100 2.2× 61 1.6× 24 0.8× 23 579
Rachel E. Brown United States 12 180 0.7× 68 0.5× 57 1.3× 61 1.6× 53 1.8× 33 474
Haley M. Scott United States 5 250 1.0× 36 0.3× 24 0.5× 46 1.2× 16 0.5× 5 340
Yunmeng Bai China 11 173 0.7× 81 0.6× 73 1.6× 39 1.0× 48 1.6× 30 387
Bo Shao China 14 477 1.8× 329 2.3× 50 1.1× 25 0.7× 61 2.0× 19 674

Countries citing papers authored by Ranwei Li

Since Specialization
Citations

This map shows the geographic impact of Ranwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranwei Li more than expected).

Fields of papers citing papers by Ranwei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranwei Li. The network helps show where Ranwei Li may publish in the future.

Co-authorship network of co-authors of Ranwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ranwei Li. A scholar is included among the top collaborators of Ranwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranwei Li. Ranwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Qin, et al.. (2025). NIR-activated phototherapy for targeted therapy of MRSA-induced wound infection and pneumonia. Chinese Chemical Letters. 111970–111970.
2.
Li, Ranwei, et al.. (2024). PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer. Biochemical and Biophysical Research Communications. 704. 149703–149703. 1 indexed citations
3.
Di, Xin, Shan Cong, Chang Fu Tian, et al.. (2023). RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC. Life Sciences. 315. 121359–121359. 14 indexed citations
4.
Tian, Chang Fu, et al.. (2022). Extracellular vesicles participate in the pathogenesis of sepsis. Frontiers in Cellular and Infection Microbiology. 12. 1018692–1018692. 17 indexed citations
5.
Cong, Shan, Xin Di, Ranwei Li, et al.. (2022). RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC. Cancer Cell International. 22(1). 338–338. 18 indexed citations
6.
Di, Xin, et al.. (2021). RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis. Frontiers in Oncology. 11. 603932–603932. 27 indexed citations
7.
Ding, Feng, et al.. (2021). Robust Centralized CFAR Detection for Multistatic Sonar Systems. Chinese Journal of Electronics. 30(2). 322–330. 4 indexed citations
8.
Wang, Yan, Shan Cong, Qinghua Zhang, Ranwei Li, & Ke Wang. (2020). <p>iTRAQ-Based Proteomics Reveals Potential Anti-Virulence Targets for ESBL-Producing <em>Klebsiella pneumoniae</em></p>. Infection and Drug Resistance. Volume 13. 2891–2899. 7 indexed citations
9.
Yang, Xiao, Xiuyan Wang, Qiushuang Zhang, et al.. (2020). Polydopamine-assisted PDGF-BB immobilization on PLGA fibrous substrate enhances wound healing via regulating anti-inflammatory and cytokine secretion. PLoS ONE. 15(9). e0239366–e0239366. 24 indexed citations
10.
Li, Ranwei, et al.. (2020). Multidimensional Information Fusion in Active Sonar via the Generalized Labeled Multi-Bernoulli Filter. IEEE Access. 8. 211335–211347. 3 indexed citations
12.
Li, Ranwei, et al.. (2019). ITRAQ-based proteomic analysis reveals possible target-related proteins in human adrenocortical adenomas. BMC Genomics. 20(1). 655–655. 5 indexed citations
13.
Di, Xin, Xin Jin, Ranwei Li, Min Zhao, & Ke Wang. (2019). CircRNAs and lung cancer: Biomarkers and master regulators. Life Sciences. 220. 177–185. 72 indexed citations
14.
Li, Ranwei, et al.. (2019). Chromosome 1q21 translocation and spermatogenesis failure. Medicine. 98(52). e18588–e18588. 4 indexed citations
15.
Di, Xin, Xin Jin, Ruimin Wang, et al.. (2019). The Oncogene IARS2 Promotes Non-small Cell Lung Cancer Tumorigenesis by Activating the AKT/MTOR Pathway. Frontiers in Oncology. 9. 393–393. 28 indexed citations
16.
Jin, Xin, Xin Di, Ruimin Wang, et al.. (2019). RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway. Journal of Cellular and Molecular Medicine. 23(6). 3897–3904. 37 indexed citations
17.
Li, Ranwei, et al.. (2019). Robust adaptive beamforming method for active sonar in single snapshot. SHILAP Revista de lepidopterología. 283. 3006–3006. 2 indexed citations
18.
Su, Zhenzhong, Ke Wang, Ranwei Li, et al.. (2016). Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells. World Journal of Surgical Oncology. 14(1). 57–57. 16 indexed citations
19.
Su, Zhenzhong, Lijing Zhao, Ranwei Li, et al.. (2014). Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells. World Journal of Surgical Oncology. 12(1). 367–367. 11 indexed citations
20.
Zhao, Lijing, Ranwei Li, Chen Shao, et al.. (2012). 3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis. World Journal of Surgical Oncology. 10(1). 247–247. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026